Hayward, CA – January 16, 2018 – Biolog, Inc. announced today the launch of a new product line that enables a comprehensive scan of mitochondrial function. Better technology for measuring mitochondrial function has, for many years, been on the wish list of researchers studying a wide range of human disorders. The new products, MitoPlate™ S-1 and...Read More
Hayward, CA – November 13, 2017 – Biolog, Inc. announced today that it has been granted US Patent 9,662,372 describing a new potential approach for treating life-threatening infections by the colon residing bacterium, Clostridium difficile (recently renamed as Peptoclostridium difficile). The patent describes the discovery by Biolog scientists that cationic compounds can rapidly inactivate the toxin produced by this...Read More
Hayward, CA – April 3, 2017 – Biolog, Inc. announced today details of its latest GEN III identification database version 2.8, containing 1568 taxa, including 258 plant pathogens. This database update was completed by scientists at Biolog’s headquarters in Hayward, CA in collaboration with Dr. Bevan Weir and his colleagues at Landcare Research in Auckland, New...Read More
Biolog is a world leader in cell-based phenotypic testing technologies and assays. We have focused our efforts on developing technologies and products to test properties of cells (phenotypes) very simply and efficiently.